ANIP: ANI Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,390.99
Enterprise Value ($M) 1,480.39
Book Value ($M) 457.60
Book Value / Share 21.81
Price / Book 3.04
NCAV ($M) 72.99
NCAV / Share 3.48
Price / NCAV 19.06

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.06

Liquidity (mrq)
Quick Ratio 2.81
Current Ratio 3.57

Balance Sheet (mrq) ($M)
Current Assets 519.82
Assets 904.42
Liabilities 446.82
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 486.82
Operating Income 49.53
Net Income 18.78
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 118.96
Cash from Investing -18.51
Cash from Financing 67.44

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-14 13D/A Meridian Venture Partners II GP, L.P. 6.90 -13.88
02-13 13G Vanguard Group Inc 6.31
02-12 13G Rubric Capital Management LP 5.51
01-23 13G/A BlackRock Inc. 12.40 27.30
01-17 13D/A Esjay LLC 4.80 -4.83

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 o TRANSITION REPORT UNDER SECTION
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-16 13,555 86,481 15.67
2024-04-15 13,740 75,586 18.18
2024-04-12 13,051 37,011 35.26
2024-04-11 27,747 47,511 58.40

(click for more detail)

Similar Companies
ALIM – Alimera Sciences, Inc. ALPN – Alpine Immune Sciences, Inc.
ALT – Altimmune, Inc. APGE – Apogee Therapeutics, Inc.
APLT – Applied Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io